Fibryga® Receives FDA Approval for New 2-Gram Presentation to Optimize Fibrinogen Treatment The FDA has approved a new 2-gram presentation of Fibryga®, enhancing treatment options for patients with acquired fibrinogen deficiency. This innovation aims to improve emergency response in critical bleeding situations.

Fibryga® Receives FDA Approval for New 2-Gram Presentation to Optimize Fibrinogen Treatment #USA #FDA #Paramus #hemostasis #Fibryga